These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. Gershon AA, Steinberg SP. N Engl J Med; 1989 Apr 06; 320(14):892-7. PubMed ID: 2538749 [Abstract] [Full Text] [Related]
6. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, Chan I, Study Group for Varivax. Pediatr Infect Dis J; 2004 Feb 06; 23(2):132-7. PubMed ID: 14872179 [Abstract] [Full Text] [Related]
8. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Watson BM, Piercy SA, Plotkin SA, Starr SE. Pediatrics; 1993 Jan 06; 91(1):17-22. PubMed ID: 8416499 [Abstract] [Full Text] [Related]
9. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine. Asano Y, Nagai T, Miyata T, Yazaki T, Ito S, Yamanishi K, Takahashi M. Pediatrics; 1985 Apr 06; 75(4):667-71. PubMed ID: 2984636 [Abstract] [Full Text] [Related]
11. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Bernstein HH, Rothstein EP, Watson BM, Reisinger KS, Blatter MM, Wellman CO, Chartrand SA, Cho I, Ngai A, White CJ. Pediatrics; 1993 Dec 06; 92(6):833-7. PubMed ID: 8233746 [Abstract] [Full Text] [Related]
12. Chickenpox vaccination of healthy children: immunological and clinical responses and protective effect in 1978-1982. Horiuchi K. Biken J; 1984 Sep 06; 27(2-3):37-8. PubMed ID: 6100055 [Abstract] [Full Text] [Related]
13. Live attenuated varicella vaccine in children with leukemia in remission. Gershon AA, Steinberg S, Galasso G, Borkowsky W, Larussa P, Ferrara A, Gelb L. Biken J; 1984 Sep 06; 27(2-3):77-81. PubMed ID: 6100063 [Abstract] [Full Text] [Related]
15. Study of tolerance and effectiveness of a varicella vaccine in leukemic children. Bancillon A, Leblanc T, Baruchel A, Schaison G, Leverger G, Mallarmey D, Teuliere L. Nouv Rev Fr Hematol (1978); 1991 Sep 06; 33(6):555-6. PubMed ID: 1667953 [Abstract] [Full Text] [Related]
16. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays. Asano Y, Albrecht P, Vujcic LK, Quinnan GV, Kawakami K, Takahashi M. Pediatrics; 1983 Sep 06; 72(3):291-4. PubMed ID: 6310478 [Abstract] [Full Text] [Related]
17. Clinical application of a live varicella vaccine (Oka strain) in a hospital. Naganuma Y, Osawa S, Takahashi R. Biken J; 1984 Sep 06; 27(2-3):59-61. PubMed ID: 6100059 [Abstract] [Full Text] [Related]
19. Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months. Ramkissoon A, Coovadia HM, Jugnundan P, Haffejee IE, Meurice F, Vandevoorde D. S Afr Med J; 1995 Dec 06; 85(12):1295-8. PubMed ID: 8600589 [Abstract] [Full Text] [Related]
20. Immunogenicity of subcutaneous versus intramuscular Oka/Merck varicella vaccination in healthy children. Dennehy PH, Reisinger KS, Blatter MM, Veloudis BA. Pediatrics; 1991 Sep 06; 88(3):604-7. PubMed ID: 1881743 [Abstract] [Full Text] [Related] Page: [Next] [New Search]